Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_assertion type Assertion NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_head.
- NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_assertion description "[MUC4 was only significant to predict recurrence-free survival, and MUC5AC could be a good marker in stage IV colorectal cancers that require additional chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_provenance.
- NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_assertion evidence source_evidence_literature NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_provenance.
- NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_assertion SIO_000772 23566254 NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_provenance.
- NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_assertion wasDerivedFrom befree-20150227 NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_provenance.
- NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_assertion wasGeneratedBy ECO_0000203 NP579637.RAX2nsqF2TbQ_P2waJXZx-HuXaNwaK9t9-qOXGuZYfagA130_provenance.